Evaluation of Drug Efficacy in a Rodent Model of Neuropathic Pain
Closed Solicitation Posted
- Solicitation number
- 75N95021Q00118
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
Notice details come from SAM.gov. Updated .
Notice text
There is an unmet medical need for safer, less addictive, and more effective solutions for chronic pain management. Current methods involving the prescription of opioids to patients with chronic pain has led to an unsustainable and deadly epidemic of addiction. Alternative methods of treating pain are therefore required to mitigate opioid substance abuse and addiction.
The object of this project is to establish the efficacy of the nanoparticle formulation by replicating previous research investigations that compared the nanoparticle formulation to a free drug formulation. The scope of this project is for the contractor to execute the neuropathic pain model in adult rodents, treat animals with the compounds, and evaluate drug efficacy at different doses by measuring evoked and spontaneous pain. Specifically, the contractor shall perform a Mouse SNS (Sural Nerve Spared) model of neuropathic pain with use of von Frey Hairs (vFH) for assessment of mechanical allodynia.
See attached Request for Quotations, Statement of Work, and other attachments for complete requirement details.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Evaluation of Drug Efficacy in a Rat Model of Neuropathic Pain | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity